Stocksigma LogoStocksigma Logo

Max Healthcare Delivers Strong H1 FY27 Growth with Aggressive Capacity Expansion Plans

Max Healthcare reported H1 FY27 consolidated gross revenue of ₹6,200 Cr (up 18% YoY) and operating EBITDA of ₹1,524 Cr (up 17% YoY) at a 25.9% margin

Max Healthcare Delivers Strong H1 FY27 Growth with Aggressive Capacity Expansion Plans

Max Healthcare Institute Ltd · Investor Presentation · 14 Nov 2026, 3:56 am

Max Healthcare Delivers Strong H1 FY27 Growth with Aggressive Capacity Expansion Plans Max Healthcare reported H1 FY27 consolidated gross revenue of ₹6,200 Cr (up 18% YoY) and operating EBITDA of ₹1,524 Cr (up 17% YoY) at a 25.9% margin. Q2 FY27 gross revenue increased 20% YoY to ₹3,219 Cr, with operating EBITDA reaching ₹820 Cr. Operating 21 facilities with 6,000+ beds (71% in metros, 76% H1 FY27 occupancy), the network plans to add ~4,600 beds over the next 3–4 years, with a total pipeline of 8,900+ beds, supported by ₹897 Cr H1 cash flow from operations.

Original exchange filing (PDF)

More announcements from Max Healthcare Institute Ltd

All Max Healthcare Institute Ltd announcements